| Daniel Young Parkinson, MD | |
|
69 West Exchange Street, St Josephs Hospital, St Paul, MN 55102 | |
| (651) 232-3000 | |
| Not Available |
| Full Name | Daniel Young Parkinson |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 35 Years |
| Location | 69 West Exchange Street, St Paul, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770574196 | NPI | - | NPPES |
| 1531957 | Other | MN | MEDICA |
| 28F43PA | Other | MN | BCBS OF MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 38561 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Health Services | 1951213057 | 559 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Entity Name | Healtheast Woodwinds Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309322 PECOS PAC ID: 9638082563 Enrollment ID: O20031107000110 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Entity Name | Range Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669569265 PECOS PAC ID: 8022920024 Enrollment ID: O20031110000095 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Entity Name | Healtheast St John's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447218482 PECOS PAC ID: 9234035742 Enrollment ID: O20031208000320 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Entity Name | Healtheast Care System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194787465 PECOS PAC ID: 7214833763 Enrollment ID: O20031208000483 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Young Parkinson, MD Po Box 365, Monticello, MN 55362-0365 Ph: (612) 710-3671 | Daniel Young Parkinson, MD 69 West Exchange Street, St Josephs Hospital, St Paul, MN 55102 Ph: (651) 232-3000 |
News Archive
The United Kingdom last night signed an Agreement with the Governments of Ireland, Canada, USA, Australia and New Zealand to tackle animal disease outbreaks.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
› Verified 3 days ago
Suzanne B Harris, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 640 Jackson St, Healthpartners Regions Behavioral Mail Stop 11303a, St Paul, MN 55101 Phone: 651-254-4786 Fax: 651-254-9426 | |
Carol E Novak, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 640 Jackson Street, Mail Stop 11303a, St Paul, MN 55101 Phone: 651-254-4786 Fax: 651-228-8362 | |
Alex Solovey, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Mail Stop 11303a, St Paul, MN 55101 Phone: 651-254-4786 Fax: 651-228-8362 | |
Craig Jon Vine, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2550 University Avenue West, Suite 229n, St Paul, MN 55114 Phone: 651-645-3115 Fax: 651-645-2752 | |
Mario R Quinones, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 401 Phalen Boulevard, Mail Stop 41104c, St Paul, MN 55101 Phone: 651-254-7900 Fax: 651-254-7908 | |
Dr. Tracy A Tomac, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St Mail Stop 11302c, Healthpartners Regions Behavioral Health-st Paul, St Paul, MN 55101 Phone: 651-254-4786 Fax: 651-254-9426 | |
Dr. Wangcai Gao, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 225 Smith Ave N #500, St Paul, MN 55102 Phone: 651-241-6550 |